People · Operator
Named in public records as an officer, director or promoter · active 2024–2025 · Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Click Therapeutics, Inc. | — | Pharma | Series C | $136.7M | $332.4M | 2024 |
Jeffrey B. Berkowitz at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jeffrey B. Berkowitz on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Klein | 1 | 10 |
| LEE SHAPIRO | 1 | 10 |
| Uri Geiger | 1 | 6 |
| Jeffrey Berkowitz | 1 | 3 |
| Alex Zisson | 1 | 3 |
| Muzammil Mansuri | 1 | 3 |
| Randall Stanicky | 1 | 2 |
| JOHN SADOWSKI | 1 | 2 |
| Alex B. Zisson | 1 | 1 |
| Cris B. De Luca | 1 | 1 |
| David B. Klein | 1 | 1 |
| David B. Friedman | 1 | 1 |
| Muzammil B. Mansuri | 1 | 1 |
| Randall B. Stanicky | 1 | 1 |
| Maria Forero | 1 | 1 |
| Cris De Luca | 1 | 1 |
| Lezrene Cunningham | 1 | 1 |
| Jeff Berkowitz | 1 | 1 |
| Ted Silver | 1 | 1 |
| Nicholas Schork | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.